ARCHIVES

Group Chairs Urge NCI to Limit Authority of Steering Committees That Determine Which Trials Get Funded

This article is from The Cancer Letter archive.

Vol. 37 No. 31 | August 5, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001

Vaccine and LDCT Pretreatment Can Help PDACs Become Vulnerable to Immunotherapy

June 27, 2014

Letters: NCI Mammography Statement Recognizes Patient Autonomy

February 25, 1994

Funding Opportunities.

March 22, 2002

NCI Bypass Budget For FY99 Proposes Expansion of Cancer Clinical Trials System

December 5, 1997

In Brief: Rosenberg To Give Karnofsky Lecture at ASCO, Minna To Present Rosenthal Lecture At AACR

April 27, 1984